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Mieap,ap53-inducibleprotein,controlsmitochondrialintegritybyinducingtheaccumulationoflysosomal
proteinswithinmitochondria.ThisphenomenonisdesignatedMALM,forMieap-inducedaccumulationof
lysosome-like organelles within mitochondria. To identify this novel Mieap-interacting protein(s), we
performed a two-dimensional image-converted analysis of liquid chromatography and mass spectrometry
(2DICAL)ontheproteinsimmunoprecipitatedbyananti-Mieapantibody.Weindentified14-3-3casoneof
the proteins that was included in the Mieap-binding protein complex when MALM was induced. The
interaction between Mieap and 14-3-3c was confirmed on the exogenous and endogenous proteins.
Interestingly, 14-3-3c was localized within mitochondria when MALM occurred. A 14-3-3c deficiency did
not affect the accumulation of Mieap and lysosomal proteins within mitochondria, but dramatically
inhibited the elimination of oxidized mitochondrial proteins. These results suggest that 14-3-3c plays a
critical role in eliminating oxidized mitochondrial proteins during the MALM process by interacting with
Mieap within mitochondria.
M
itochondria are the sites of oxidative phosphorylation for cellular energy, a process that inevitably
generates reactive oxygen species (ROS) as byproducts
1,2. Therefore, mitochondria are a major source
of ROS, and they are consequently highly susceptible to ROS damage. Damaged mitochondria produce
much higher levels of ROS than do intact mitochondria. This increase may be due to abnormal electron transfer
by dysfunctional respiratory chain proteins, impaired ATP production by dysfunctional ATP synthase proteins,
and/or decreased NADHsupply caused bydysfunctional TCA cycle proteins. TheseROS alsooxidize mitochon-
drialproteins,includingthecoreproteinsofenergyproduction,leadingtoaviciouscycleandanaccumulationof
unhealthy mitochondria
3,4. Furthermore, the ROS generated by unhealthy mitochondria oxidize and damage
intracellular DNA, RNA, lipids, and proteins, thereby leading to a variety of cellular dysfunctions, including
degenerativediseases,cancer,andaging
5,6.Therefore,efficientlyeliminatingoxidizedmitochondrialproteinsand
preventing mitochondrial ROS generation are critical for mitochondrial quality control.
Mieap, a p53-inducible protein, was originally identified as a key regulator of a novel mitochondrial repair
system
7; this phenomenon, which is designated MALM (for Mieap-induced accumulation of lysosome-like
organelles within mitochondria), is critically different from canonical autophagy
7. In this mechanism, Mieap
induces an accumulation of intramitochondrial lysosomal proteins to eliminate oxidized mitochondrial proteins
in response to mitochondrial damage
7. This process leads to a decrease in ROS generation and an increase in
mitochondrial ATP synthesis activity
7. Therefore, this function likely mediates the repair of unhealthy mito-
chondria. Alternatively, another mechanism has been designated MIV, for Mieap-induced vacuole
8. When
MALM is inhibited, Mieap induces a vacuole-like structure known as the MIV. The MIV engulfs damaged
mitochondria and fuses with lysosomes, leading to degradation of the unhealthy mitochondria. The function
of theMIVislikelytoactasatypeof mitochondrialautophagy. Therefore,Mieapcontrols mitochondrialquality
by repairing or eliminating unhealthy mitochondria via MALM or MIV generation, respectively
7,8. Inactivating
p53 or Mieap severely impairs both MALM and MIV, leading to an accumulation of unhealthy mitochondria
7,8.
Although Mieap-mediated mitochondrial quality control appears to be critical for a variety of diseases and
biological responses, a large part of the mechanism still remains to be elucidated.
Although an accumulation of lysosomal proteins within the intramitochondrial space is evident from consid-
erabledataobtainedinpreviousstudies
7,weareunawareofanymoleculesproventoberelatedtotheprocessesof
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SCIENTIFIC REPORTS | 2 : 379 | DOI: 10.1038/srep00379 1Figure 1 | Identifying14-3-3casaMieap-bindingproteinbyIP-2DICAL. (a)PreparationofthesamplesforidentifyingendogenousMieap-interacting
proteinsby IP-2DICAL. The A549 cells were c-irradiated, and40 h after thisionizing radiation (IR), the cell lysates were immunoprecipitated withanti-
Mieap antibody (Mieap) or normal rabbit globulin (rIgG), as indicated. The immunoprecipitates were blotted with anti-Mieap antibody. Pre: total cell
lysate before IP, Post: total cell lysate after IP, and IP: immunoprecipitated proteins. (b) A two-dimensional display of all (.33,000) the MS peaks in a
representativesamplepreparedasin(a),withthem/z-value(350–1,600 m/z)alongthehorizontal(x)axisandtheLCRT(10–110 min)alongthevertical
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unhealthymitochondria,translocatinglysosomalproteinsintomito-
chondria, and degrading oxidized mitochondrial proteins. Despite
the complexity of the MALM mechanisms, few molecules have been
identified as MALM related. Therefore, a comprehensive identifica-
tion of MALM-related molecules is required for elucidating the
MALMregulatorymechanisms.Consequently,wesoughttoidentify
novel candidate MALM-related proteins by analyzing the cellular
polypeptides that bind to Mieap under MALM-induced conditions.
To achieve this aim, we used two-dimensional image-converted
analyses of liquid chromatography (LC) and mass spectrometry
(MS) (2DICAL) to examine immunoprecipitates and identify
Mieap-interacting proteins. 2DICAL is a labeling-free, MS-based
quantitative proteomics platform
9. In 2DICAL, large peptide data
sets are defined as peaks in a single two-dimensional image with
m/z values along the x-axis and retention time (RT) along the y-axis.
The peaks derived from different LC-MS runs align accurately with
high sensitivity and reproducibility, allowing quantitative compari-
sons and successful implementations of experiments with large
numbers of samples
10–14. This property of 2DICAL enables us to
determine quantitative differences in immunoprecipitates between
samples. Using this method, it is possible to select the proteins of
interest that are significantly different between two or more immu-
noprecipitates. We designated this method as ‘‘immunoprecipita-
tion-2DICAL’’ (IP-2DICAL).
Here, we describe identifying 14-3-3c, a member of the 14-3-3
family of proteins, as a Mieap-interacting protein by IP-2DICAL.
We demonstrated that 14-3-3c is translocated from the cytoplasm
to an intramitochondrial space during MALM. Furthermore, we
showed that intramitochondrial 14-3-3c is involved in degrading
oxidized mitochondrial proteins.
Results
Identification of 14-3-3c as a novel Mieap-interacting protein by
IP-2DICAL. To clarify the MALM mechanism, we attempted to
identify Mieap-interacting proteins. For this purpose, we developed
the IP-2DICAL strategy depicted in Supplementary Figure S1. The
immunoprecipitates were prepared from MALM-induced A549 cells
using an anti-Mieap antibody and normal rabbit globulin (rIgG) as a
control. Western blotting with the Mieap antibody indicated that
endogenous Mieap was clearly immunoprecipitated in the Mieap-
immunoprecipitated samples (Fig. 1a, lane Mieap & IP) but not in
the control rIgG-immunoprecipitated samples (Fig. 1a, lane rIgG &
IP). Mixtures of the proteins eluted fromthe immunoprecipitates were
trypsinized, and the MS spectral data obtained were analyzed by
2DICAL. A total of 33,723 independent MS peaks within the 350–
1,600-m/z mass range with an LC RT of 10–110 min were determined
to be comparable between the samples (Fig. 1b).
We found 3,201 peaks for which the average intensity of the dupli-
cates exhibited a statistically significant increase in the Mieap immuno-
precipitates (.2-fold difference inintensity, P,0.01 [T-test]). The MS/
MS spectra of the 3,201 peaks were matched against the contents of the
SwissProt database using the Mascot software package (version 2.2.1)
(Matrix Science, London, UK), and dozens of proteins were identified as
Mieap-interacting protein candidates with significance values below
0.05 (data not shown). In these candidates, we identified two MS/MS
spectrum peaks at 540 m/z (34.9 min) and 822 m/z (44.3 min) that
matched the YLAEVATGEK and NVTELNEPLSNEER sequences,
respectively, of 14-3-3c (NP_036611) with the highest Mascot scores
(Supplementary Fig. S2).
The 2DICAL reports for various two-dimensional views of these
peaks revealed significant differences between the Mieap- and rIgG-
immunoprecipitated samples (Fig. 1c and Supplementary Fig. S3).
Although the 14-3-3 isoforms are known to be highly homologous
proteins with approximately 50% amino acid identity, two peptide
sequences could be identified as being derived from 14-3-3c
(Supplementary Fig. S4). Because 14-3-3 proteins are major regula-
tors of various proteins that are involved in diverse cellular pro-
cesses
15, we decided to focus on 14-3-3c’s interaction with Mieap
among the Mieap-interacting protein candidates.
To confirm the interaction of Mieap and 14-3-3c, endogenous
Mieap was immunoprecipitated from the MALM-induced A549
cells. Western blotting with anti-14-3-3c antibody indicated that
14-3-3c was coprecipitated with endogenous Mieap under physio-
logical conditions, while no 14-3-3c was coprecipitated with control
rIgG (Fig. 1d).
Endogenous Mieap has two alternative splicing variants, termed
Mieap a and Mieap b, although the functional differences between
endogenous Mieap a and b have yet to be elucidated [7, 8]. To
determine whether Mieap a, Mieap b, or both variants interact with
14-3-3c, HCT116 cells (in which endogenous Mieap expression is
completelysuppressed bymethylationoftheMieappromoter
7)were
transfectedwiththeseconstructs,andcoimmunoprecipitationassays
were performed. Our results indicated that similar amounts of 14-3-
3c were co-precipitated with both Mieap a and Mieap b (Fig. 1e).
Reciprocal immunoprecipitation experiments also confirmed that
Mieap a and Mieap b can be co-immunoprecipitated with 14-3-3c
(Fig. 1e). These results demonstrated that Mieap is associated with
14-3-3c during the process of MALM, suggesting that 14-3-3c may
play a role in Mieap function.
MappingoftheinteractiondomainsofMieapand14-3-3c.Several
deletionmutantsofMieapaandbwereconstructedtodeterminethe
region responsible for their interaction with 14-3-3c (Fig. 2a). Our
results indicated that the N-terminal regions of Mieap a and b (DCt:
a 1–273 and b 1–241), were sufficient for interaction with 14-3-3c
(Fig. 2b). We further confirmed that the coiled-coil domain-deleted
Mieapmutant(DCC)alsoassociateswith14-3-3catalevelsimilarto
that of the full a and full b Mieap proteins, suggesting that 14-3-3c
interacts with Mieap via its 1–103 amino acid region (Fig. 2b). To
confirmthishypothesis,weconstructedbothMieapaandbmutants
bydeleting aminoacids 1–103anddesignated themDNt (a 104–538
and b 104–506) (Fig. 2a). As expected, these deletion mutants could
(y)axis.(c)Thepeakat540 m/zand34.9 mindisplayedinvariouscombinationsofaxes.Theimmunoprecipitatesgeneratedbytheanti-Mieapantibody
are indicated in red and the immunoprecipitates from the control rIgG are indicated in blue. Upper left, the m/z and intensity axes, with indicators of the
isotopicmass(lightbluelineanddot).Lowerleft,agray-scaleintensitypatternoftheRT(xaxis)andsample(yaxis).Upperright,thesampleandintensity
axes (left) and a box-and-whisker diagram of the immunoprecipitates generated using anti-Mieap antibody and rIgG (right). Lower right, the m/z and RT
axeswithhigh(upper)andlow(lower)intensitiesareindicatedbyareddot.(d)Theinteractionofendogenous14-3-3candMieapproteins.Theirradiated
A549 cell lysates were generated as in (a) and were subjected to immunoprecipitation with the anti-Mieap antibody (Mieap). Immunoprecipitates
generated using rIgG were employed as a control (rIgG). The immunoblot analysis was performed using the anti-14-3-3c and anti-Mieap antibodies.
Lysate: total cell lysate and IP: immunoprecipitated proteins. (e) The interaction of exogenous 14-3-3c and Mieap proteins. The HCT116 cells were co-
transfected with FLAG-tagged 14-3-3c and HA-tagged Mieap a or b. The transfected cells were c-irradiated, and 72 h after IR, the cell lysates were
immunoprecipitated with anti-FLAG or anti-HA antibodies. Immunoblot analysis was carried out with the anti-FLAG or anti-HA antibodies. IB:
immunoblotting, IP: immunoprecipitation, and lysate: total cell lysate.
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SCIENTIFIC REPORTS | 2 : 379 | DOI: 10.1038/srep00379 3Figure 2 | Mapping of the domains responsible for the interaction between Mieap and 14-3-3c. (a) The Mieap and 14-3-3c deletion mutants. The
numbers of amino acid residues are indicated. (b and c) Mieap interacts with 14-3-3c via the N-terminal region of Mieap. The HCT116 cells were co-
transfectedwithFLAG-tagged14-3-3candvariousHA-taggedMieapmutantsandwerec-irradiated.Seventy-twohoursaftertheIR,thecelllysateswere
immunoprecipitated withanti-HAantibody.Animmunoblot analysiswasperformedusingtheanti-FLAGoranti-HAantibody.a:Mieapa,b:Mieapb,
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103 Mieap fragment contains the 14-3-3c-binding site.
To determine which region of 14-3-3c is responsible for the inter-
action with Mieap, two 14-3-3c deletion mutants were constructed
next: the protein-binding (PB) domain-deficient 14-3-3c (14-3-3c
1–166) and the dimerization (DM) domain-deficient 14-3-3c (14-3-
3c 139–247) mutants (Fig. 2a)
16. As shown in Fig. 2d, 14-3-3c 139–
247wasabletobindtobothMieapaandbproteins.However,14-3-
3c 1–166 displayed impaired binding with Mieap b but was able to
bindtoMieapa.Consistent withthe prior reports, thePB domainof
14-3-3clikelyplaysacriticalroleintheMieapbinteraction,butboth
the PB and DM domains of 14-3-3c can be independently sufficient
for interaction with Mieap a.
Translocation of 14-3-3c from the cytoplasm to the inside of
mitochondria. To clarify the subcellular location where 14-3-3c
interacts with Mieap, we performed immunofluorescence (IF)
experiments with the anti-14-3-3c antibody using Mieap-
methylated HCT116 cells (for exogenous Mieap) and Mieap-
unmethylated A549 cells (for endogenous Mieap). To induce
MALM, the HCT116 cells were infected with Ad-Mieap b (Mieap
bexpressingadenovirus)atamultiplicityofinfection(MOI)of5and
the A549 cells were c-irradiated at 10 Gy, as has been previously
described
7,8. The IF experiments were performed three days after
the infection or ionizing radiation (IR).
AsshowninFig.3a,14-3-3cwasmainlylocalizedinthecytoplasm
of the Ad-LacZ-infected HCT116 cells. Once MALM wasinduced in
the cells by infection with Ad-Mieap b, however, 14-3-3c clearly
colocalized with the DsRed-mito, Mieap, and LAMP1 in the
MALM-induced cells (Fig. 3a), implying that 14-3-3c is translocated
from the cytoplasm to the mitochondria and interacts with Mieap in
the mitochondria when MALM occurs; similar results with endo-
genous Mieap protein were obtained using IR-treated A549 cells
(Supplementary Fig. S5).
Toobtainamoredetailedlocalizationof14-3-3cinmitochondria,
we performed proteinase K protection assays with mitochon-
drial fractions prepared from MALM-induced and non-MALM
HCT116 and A549 cells. In this experiment, the mitochondria-rich
fraction was incubated with proteinase K, a general protease that
degrades all proteins in the fraction, which do not present within
mitochondria. If a protein is localized within mitochondria, the pro-
tein is protected from proteinase K digestion and can be detected by
Western blot analysis following incubation with proteinase K.
ToinduceMALM,theHCT116cellswereinfectedwithAd-Mieap
a or Ad-Mieap b at an MOI of 5. As previously reported, the Mieap
and cathepsin D proteins in the mitochondrial fraction from the
MALM-induced cells (Fig. 3b, lanes a and b) were protected from
proteinase K digestion in parallel with the two intramitochondrial
proteins (ATP synthase a and mitofilin), while the cathepsin D pro-
teinwasdegradedbyproteinaseK,similartothethreemitochondrial
outer membrane proteins (NIX, VDAC, and TOMM70A) in the
non-MALM cells (Fig. 3b, lane C). Interestingly, the 14-3-3c levels
in the mitochondrial fraction were markedly increased in the
MALM-induced cells, while little 14-3-3c was detected in the mito-
chondrial fraction prepared from the MALM non-induced cells
(Fig. 3b, lanes C, a, and b). Surprisingly, the 14-3-3c protein in the
mitochondrial fraction prepared from the MALM-induced HCT116
cells was resistant to proteinase K digestion (Fig. 3b, lanes C, a, and
b). This result indicated that the 14-3-3c protein is present within
mitochondria. A similar result was obtained from the IR-treated
A549 cells, in which endogenous Mieap was activated by IR and
MALMwasinducedbyendogenousMieap(Fig.3c).Takentogether,
these results suggest that 14-3-3c is translocated from the cytoplasm
to the inside of mitochondria through the interaction with Mieap
during the process of MALM.
Fig. 3c also indicates that the endogenous Mieap b protein was
preferentially localized to mitochondria and translocated into the
inside of mitochondria during MALM, while the Mieap a protein
was preferentially localized to the cytoplasm (Fig. 3c). The data sug-
gests that Mieap b may play a specific functional role in MALM
under physiological conditions.
Potential role of 14-3-3c in the elimination of oxidized mito-
chondrial proteins. To further explore the role of 14-3-3c in
Mieap-regulated mitochondrial quality control, we established 14-
3-3c knockdown (14-3-3c KD) cells using the HCT116 and A549
cells.Weconfirmedthat14-3-3cexpressionwasseverelyinhibitedin
the 14-3-3c KD HCT116 and A549 cells (Supplementary Fig. S6).
Usingthesecelllines,wefirstperformedaproteinaseKprotection
assaytoexaminewhether14-3-3cdeficiencyaffectsthetranslocation
of Mieap and lysosomal proteins to the inside of mitochondria dur-
ing MALM. As shown in Fig. 4a, when MALM was induced by
endogenous Mieap, we clearly observed the accumulation of the
Mieap and cathepsin D proteins within mitochondria in the 14-3-
3cKDA549cells,implyingthat14-3-3cisnotinvolvedinregulating
mitochondrial translocation during MALM.
Because MALM degrades oxidized mitochondrial proteins
7,w e
nextexamined theroleof14-3-3cinthisprocess. First,weexamined
the oxidative modification of the carbonyl groups in the protein side
chains. Interestingly, oxidized proteins accumulated in the Mieap
KD and the 14-3-3c KD A549 cells, even in the absence of stress
(Fig. 4b). After the IR, the accumulation of oxidized proteins was
enhanced in both the Mieap KD and 14-3-3c KD A549 cells, but not
inthe controlA549 cells. Theseresults clearlysuggest that 14-3-3cis
involved in degrading oxidized proteins by MALM.
Using an antibody against nitrotyrosine, another oxidative stress
marker, we next tried to confirm the role of 14-3-3c in degrading
oxidized mitochondrial proteins by carrying out IF experiments.
Consistent with our previous study
7, the accumulation of oxidized
proteins in mitochondria was observed in the non-MALM cells
(Fig. 5a, HCT116 cont/Ad-LacZ 5moi) after the IR, while the accu-
mulationofoxidized mitochondrialproteinswassignificantlyinhib-
ited in the MALM-induced cells (Fig. 5a, HCT116 cont/Ad-Mieap b
5moi).
We confirmed that the degradation of oxidized mitochondrial
proteins, but not MALM, is severely inhibited by lysosomal enzyme
inhibitors (Fig. 5a, HCT116 cont/Ad-Mieap b 5moi/lysosomal
enzyme inhibitors) and NH4Cl (Supplementary Fig. S7a), which
neutralizes the acidic environment of lysosomes, suggesting that
lysosomal enzymes play a critical role in removing oxidized mito-
chondrial proteins.
Similarly, although the accumulation of Mieap and lysosomal
proteins within mitochondria was not inhibited, we detected the
accumulation of oxidized mitochondrial proteins in the MALM-
induced 14-3-3c KD cells (HCT116 14-3-3c KD/Ad-Mieap b
5moi) (Fig. 5a). We also confirmed similar results in the IR-treated
IP:immunoprecipitation,lysate:totalcelllysate,andIB:immunoblotting.(d)14-3-3cinteractswithMieapbviathePBdomainof14-3-3c.TheHCT116
cellswereco-transfectedwithHA-taggedMieapandvariousFLAG-tagged14-3-3cmutantsandwerec-irradiated.Seventy-twohoursaftertheIR,thecell
lysates were immunoprecipitated with anti-HA antibody. An immunoblot analysis was performed using the anti-FLAG or anti-HA antibodies. IP:
immunoprecipitation, lysate: total cell lysate, and IB: immunoblotting.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 379 | DOI: 10.1038/srep00379 5Figure 3 | Translocation of 14-3-3c from the cytoplasm to the inside of mitochondria. (a) The mitochondrial localization of 14-3-3c during MALM.
TheAd-LacZandAd-Mieap-infectedHCT116cellsweresubjectedtoIFanalysisonday3aftertheIR.The14-3-3cproteinwasstainedwithanti-14-3-3c
antibody(14-3-3c:green).TheMieapproteinwasstainedwithanti-Mieapantibody(Mieap:red).Thelysosomeswerestainedwithanti-LAMP1antibody
(LAMP1:red).ThemitochondriaareindicatedbytheDsRed-Mitoproteinsignal(Mito:red).Theyellowareaindicatesoverlappingbetween14-3-3cand
mitochondria,Mieap, orlysosomes. Aquantitative analysisoftheyellow, red,or greenarea wasperformed using300–400cells.Theaverage valuesof the
yellowtoredorgreenratios(merged/mitochondria,14-3-3c,orlysosomes;yellowbargraph)areshownwitherrorbarsindicating1SD.P,0.01(*)was
considered statistically significant. Scale bar 5 20 mm. (b and c) The intramitochondrial localization of 14-3-3c during MALM. The mitochondria were
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 379 | DOI: 10.1038/srep00379 6fractionated from the Ad-LacZ- and Ad-Mieap-infected HCT116 cells (a) or the control and Mieap-KD A549 cells (b) on day 3 after the IR. The
mitochondrial fraction was subjected to a proteinase K protection assay. (2): no treatment, (1): proteinase K treatment, Mieap: Ad-Mieap-infected
HCT116 cells, LacZ: Ad-LacZ-infected HCT116 cells, IR: ionizing radiation, Mitochondria: mitochondrial fraction, Cytosol: cytoplasmic fraction, and
Whole:wholecelllysate.(b)C:HCT116cellsinfectedwithAd-LacZ,a:HCT116cellsinfectedwithAd-Mieapa,b:HCT116cellsinfectedwithAd-Mieap
b.(c)C:A549controlcells,K:A549Mieap-KDcells,a:endogenousMieapaprotein,andb:endogenousMieapbprotein.Full-lengthblotsarepresented
in Supplementary Figure S8.
Figure 4 | 14-3-3c plays a role in degrading oxidized proteins. (a) 14-3-3c does not affect the accumulation of Mieap and lysosomal proteins within
mitochondria. The mitochondria were fractionated from the control and 14-3-3c-KD A549 cells on day 3 after the IR. The mitochondrial fraction was
subjected to a proteinase K protection assay. ProK: Proteinase K, (2): no treatment, (1): proteinase K treatment, Control: A549 control cells, 14-3-3c-
KD:A54914-3-3c-KDcells,Mitochondria: mitochondrial fraction, Cytosol:cytoplasmic fraction, Whole:wholecell lysate, Mieapa:endogenous Mieap
a protein, and Mieap b: endogenous Mieap b protein. (b) 14-3-3c deficiency causes the accumulation of oxidized proteins. The total cell lysates isolated
fromthecontrol(1:cont),Mieap-KD(2:MieapKD),and14-3-3c-KD(3:14-3-3cKD)A549cellsonday3aftertheIR.Toevaluatetheroleoflysosomes,
lysosome enzyme inhibitors were added to the A549 control cells on day 2 after the IR (4: cont/lysosome enzyme inhibitors). Then, the cell lysates were
labeled by DNPH andsubjected toWestern blot analysis withanti-DNP antibody todetect the carbonyl-oxidized proteins. b-actin wasused asaloading
control. Full-length blots are presented in Supplementary Figure S8.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 379 | DOI: 10.1038/srep00379 7www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 379 | DOI: 10.1038/srep00379 8A54914-3-3cKDcells,implyingasimilarrolefor14-3-3cindegrad-
ing oxidized mitochondrial proteins by endogenous Mieap protein
(Fig. 5b and Supplementary Fig. S7b). These results, taken together,
suggestthat14-3-3cisinvolvedindegradingoxidizedmitochondrial
proteins by MALM.
Discussion
Immunoprecipitation is a major method used to screen the binding
partners of target proteins. In general, the immunoprecipitates are
separated by SDS-PAGE and visualized by silver staining. Then,
selected visualized protein bands are excised and subjected to in-
gel digestion with trypsin. The resulting peptides are analyzed by
MS analysis. Although silver staining is the most sensitive nonra-
dioactive detection method and is widely used for screening protein-
proteininteractions,ithassomelimitations.Forexample,visualizing
particular proteins that are less sensitive to silver is difficult when
using silver staining
17,18. In addition, quantitative comparisons of
large numbers of silver-stained proteins are difficult.
By contrast, 2DICAL can overcome these limitations because it is
highly sensitive and reproducible; 60,000–160,000 peptides can be
readily detected in a 1-h LC run and accurately quantified without
labeling
9–14. Therefore, using 2DICAL to analyze immunoprecipi-
tatesmaybecomeavaluabletoolforscreeningprotein-proteininter-
actions. In the present study, we demonstrated the utility of a novel
protein-protein interaction analysis system, IP-2DICAL, in which
two or more comparable trypsinized immunoprecipitates are
directly subjected to 2DICAL analysis. Indeed, we detected dozens
ofMieap-interactingproteincandidatesfromtheendogenousMieap
immunoprecipitates using IP-2DICAL (data not shown); among
them, we confirmed that 14-3-3c interacts with Mieap in MALM-
induced cells.
The 14-3-3 proteins constitute a family of acidic dimeric proteins
thatarehighlyconservedfromyeasttomammals
19.Crystalstructure
analyses of the 14-3-3 protein have revealed the existence of a bind-
ing groove in each 14-3-3 monomer, and cocrystallization of 14-3-3
withshortsyntheticphosphopeptides hasrevealedtheabilityofeach
monomer to independently bind a phosphopeptide, indicating that
DM-deficient14-3-3mutants canbindtargetproteinswith thesame
efficiency as wild-type 14-3-3
20–23. Consistent with these reports, the
DM-deficient 14-3-3c, but not the PB-deficient 14-3-3c, was able to
bind to the N-terminal region of Mieap b (Figure 2). However, both
the DM-deficient and PB-deficient 14-3-3c mutants were able to
bind to Mieap a. Therefore, we speculate that the PB-deficient 14-
3-3cmutantsmayinteractwithMieapabyhetero-dimerizationwith
the endogenous 14-3-3c protein; if so, 14-3-3c dimerization may be
required for 14-3-3c to interact with Mieap a. However, further
examination is absolutely needed.
In many, but not all, cases, 14-3-3 proteins bind to phosphorylated
proteins
24. A sequence analysis by Scansite (http://scansite.mit.edu/)
25
predicted the existence of three putative 14-3-3-binding sites on
Mieap a: Ser268, Ser274, and Ser507. Whether these sites are phos-
phorylated under physiological conditions remains to be elucidated.
In addition, given that these putative 14-3-3-binding sites are not
located in the 14-3-3-binding region of Mieap, these sites may not
directly affect the interaction of 14-3-3c with Mieap, even if they are
phosphorylated under physiological conditions.
TheMALMphenomenonisanovelmitochondrialqualitycontrol
system that raises many interesting biological questions
7. The first
question relates to how unhealthy mitochondria are recognized by
Mieap. We have previously reported on several experiments that
addressed this question and demonstrated that mitochondrial ROS
andNIXareessentialforMALMinduction
8.Recently,wefoundthat
BNIP3 also mediates MALM
26. We assumed that excess mitochon-
drial ROS production from unhealthy mitochondria modifies NIX,
BNIP3, and/or Mieap, and that the oxidized NIX or BNIP3 at the
outer mitochondrial membrane functions as a marker for unhealthy
mitochondria, which are the target of MALM. Indeed, Mieap inter-
acts with NIX and BNIP3 in a ROS-dependent manner, and this
interaction is required for MALM induction
8. Because 14-3-3 pro-
teins can stimulate protein-protein interactions, e.g., Raf-1 and Bcr
interactions
27, we first speculated that 14-3-3c plays an essential role
in recognizing unhealthy mitochondria by Mieap through stimulat-
ing Mieap-NIX interactions. However, the accumulation of Mieap
and lysosomal proteins in unhealthy mitochondria was observed in
the14-3-3c-deficientcellsintheIFexperiment,suggestingthat14-3-
3c is not required for this process.
The second question relates to how the cytoplasmic MALM-
related proteins, including Mieap and the components of lyso-
some-like organelles or lysosomal proteins, are translocated to the
inside of mitochondria without destroying the mitochondrial struc-
ture. Therefore, we speculated that 14-3-3c may mediate the trans-
location of these proteins and lysosome-like organelles into the
intramitochondrial space. However, the accumulation of Mieap
and lysosomal proteins within mitochondria was not inhibited in
the 14-3-3c-deficient cells in the proteinase K protection assay, sug-
gesting that 14-3-3c is not required for translocating Mieap and
lysosomal proteins from the cytosol to the inside of mitochondria.
Interestingly, we found that 14-3-3c, which is a major cytosolic pro-
tein, is also translocated from the cytosol to the inside of mitochon-
dria during MALM. Notably, a similar observation on the
localization of 14-3-3 to the mitochondrial matrix has been prev-
iouslyreportedinplantcells
28.Thesefindingssuggestthatmitochon-
dria have an undefined pore or channel that facilitates importing
cytosolic proteins that do not contain mitochondrial-targeting pre-
sequences and do not normally localize to mitochondria.
Thethirdquestionrelatestohowoxidizedmitochondrialproteins
are degraded by Mieap-regulated lysosome-like organelles or lyso-
somal proteins within mitochondria. As shown in this study, the
degradation of oxidized mitochondrial proteins by MALM is inhib-
ited by lysosomal enzyme inhibitors and by neutralizing the acidic
environment of the mitochondria with NH4Cl (Figure 4B); these
results support our speculation that lysosomes and lysosomal
enzymes are involved in this process
7. Interestingly, the degradation
of oxidized mitochondrial proteins was dramatically inhibited in the
14-3-3c-deficient cells, despite the accumulation of lysosomal pro-
teins within mitochondria. This result suggests that 14-3-3c is
involved in degrading oxidized mitochondrial proteins.
The roles of the 14-3-3 proteins have been classified into three
modes of actions: (1) directed conformational changes to the target
protein; (2)masking of aspecific region of the targetprotein; and(3)
colocalization of two proteins (scaffolding)
29. In the case of MALM,
we speculate that 14-3-3c may act as a scaffold to anchor proteins
Figure 5 | Potentialroleof14-3-3cineliminatingoxidizedproteinswithinmitochondria. (aandb)AnIFanalysisofMALMandoxidizedproteins.The
Ad-Mieap-b-orAd-LacZ-infectedcontrolandAd-Mieap-b-infected14-3-3cKDHCT116cells(a)orthecontrol,Mieap-KD,and14-3-3cKDA549cells
(b) were c-irradiated. Three days after the IR, an IF analysis was performed using anti-LAMP1 antibody (LAMP1) to detect MALM (MALM) or using
anti-nitrotyrosine antibody (Nitrotyrosine) to detect nitrotyrosine-oxidized proteins (Oxidized proteins). To evaluate the role of lysosomes, lysosome
enzymeinhibitors were addedtothe A549 control andAd-Mieap-b-infectedHCT116 control cells onday2after the IR.The mitochondria are indicated
by the DsRed-mito protein signal (Mito). Representative images are shown (upper panel of a or b). A quantitative analysis of MALM or nitrotyrosine
intensity was performed using 300-400 cells. The average intensities of the MALM or nitrotyrosine-oxidized proteins per cell are shown with error bars
indicating 1 standard deviation (SD; lower panel). P , 0.01 (*) was considered statistically significant. Scale bar 5 20 mm.
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3c may regulate the import of oxidized mitochondrial proteins into
lysosome-like organelles by mediating the interaction between
Mieap and oxidized proteins. Further investigation on this point is
needed.
MALM raises many important questions about well-established
concepts in cell biology. Identifying 14-3-3c as a Mieap-interacting
protein will facilitate the elucidation of the MALM process. In addi-
tion, our finding that 14-3-3c localizes to the intramitochondrial
spacesuggeststhatweshouldrethinktheimportingsystemformito-
chondria-localized proteins. The clarification of the exact role of 14-
3-3c and its import mechanism in MALM is a challenge for future
studies.
Methods
Cell lines. The following human cancer cell lines were purchased from the American
Type Culture Collection: HCT116 (colorectal adenocarcinomas) and A549 (lung
cancer). Cells were cultured under the conditions recommended by their depositors.
Antibodies. The anti-Mieap antibody was prepared as described previously
7.T h e
other primary antibodies used in this study were rabbit polycolonal anti 14-3-3c
antibody (Santa Cruz Biotechnology), mouse monoclonal anti-beta-actin antibody
(clone AC-74, Sigma), mouse monoclonal anti-NIX antibody (Abnova), mouse
monoclonal anti-FLAG antibody (Sigma), rat monoclonal anti-HA antibody
(Roche), mouse monoclonal anti-cathepsin D antibody (Novus Biologicals), mouse
monoclonal anti-VDAC/Porin antibody (Abcam), rabbit polyclonal anti-
TOMM70A antibody (Novus Biologicals), mouse monoclonal anti-ATP synthase
alpha antibody (Invitrogen), mouse monoclonal anti-mitofilin antibody
(Calbiochem), and mouse monoclonal anti-LAMP1 antibody (BD Pharmingen).
DNA-damaging treatments. Cells were seeded 12 h before treatment and were
60–70% confluent at the time of the treatment. To induce MALM, the cells were
c-irradiated at 10 Gy or 60 Gy using a
60Co source.
Immunoprecipitation. Immunoprecipitation was carried out at 0–4uC essentially as
described
8. Briefly, 2310
6 A549 or 5310
6 HCT116 cells were lysed on ice for 10 min
in 500 ml of ice-cold buffer A [20 mM Tris-HCl (pH 7.4), 120 mM NaCl, 50 mM b-
glycerophosphate, 5 mM NaF, and protease inhibitor (Roche)] containing 1% NP40.
After centrifugation at 20,6003g for 20 min, indicated antibody were added to the
cleared supernatant and incubated with rotation for 1 hr. Then protein A-sepharose
(Invitrogen) or protein G-sepharose (Invitrogen) was added and the incubation
continuedfor1 hr.Capturedimmunoprecipitates werewashedfivetimeswithbuffer
A. For 2DICAL analysis, 2310
7 A549 cells were subjected to immunoprecipitation.
IP-2DICAL analysis. The immunoprecipitants were released from the sepharose by
boiling them in 1% sodium deoxycholate (SDC). Then, the eluted
immunoprecipitantsweretrypsinizedinbufferB[1 Mureaand50 mMNH4HCO3].
The digested solution was acidified with 0.8% formic acid (final concentration) and
centrifuged at 20,6003g for 5 min. The supernatant was collected and equal volume
of ethyl acetate was added. The mixture was shaken for 1 min, then centrifuged at
20,6003g for 5 min to obtain aqueous and organic phases. The aqueous phase was
collected and was dried with a SpeedVac concentrator (Thermo Electron, Holbrook,
NY). The dried peptides were dissolved in 0.1% formic acid.
LC-MS. LC-MS and data acquisition were performed as reported previously
9–14.
Briefly, the peptide samples were separated with a linear gradient from 0 to 80%
acetonitrile in 0.1% formic acid at a flow rate of 200 nl/min for 60 min using the
splitless nano-flow HPLC systems (NanoFrontier nLC; Hitachi High-Technologies,
Tokyo, Japan)
9–14. MS spectra were acquired every second in duplicate with Synapt
HDMS (Waters, Milford, MA) and QSTARXL (ABSciex, Foster City, CA) for
identification of endogenous Mieap-interacting proteins.
Peak Alignment Across Multiple LC-MS. MS peaks were detected, normalized, and
quantified using the in-house 2DICAL software package, as described previously
9–14.
Protein Identification. MS/MS spectra were acquired from preparative LC. LC-MS
data were aligned and targeted MS/MS was performed. The MS/MS data were
analyzed with Mascot software (Matrix Sciences, Londn, UK).
Sequence Analysis. The amino acid sequence identity and similarity were analyzed
by using ClustalW.
Plasmids. A HA-tagged full-length human Mieap a and Mieap b (DDBJ accession
numbers AB465501 and AB465502) were cloned in pcDNA3.1 (Invitrogen) and
designatedasHA-MieapaandHA-Mieapb,respectively.Afull-lengthhuman14-3-
3c with a 33FLAG epitope at the C terminus, designated as 14-3-3c-FLAG, was
cloned in p33FLAG-CMV-14 (Sigma). The deletion mutants of HA-Mieap-a-
full(HA-Mieap-a-DCt: a1-273, HA-Mieap-a-DNt: a104-538) HA-Mieap-b-full
(HA-Mieap-b-DCt: b1-241, HA-Mieap-b-DNt: b104-506), coiled-coil-deleted
Mieap-a and b (HA-Mieap-DCC), and 14-3-3c-full (14-3-3c-(1-166)-FLAG: 14-3-
3c 1-166, 14-3-3c-(139-247)-FLAG: 14-3-3c 139-247) were generated by PCR. The
transfection with these expression vectors was carried out by using FuGENE6
Transfection Reagent (Roche) according to the manufacture’s protocol.
Immunocytochemistry. For immunocytochemistry, cells were grown on eight-well
chamber slides (2310
4 cells/well) at 37uC in conventional culture medium and fixed
in2%paraformaldehydefor10 minatroomtemperature. Slideswereincubatedwith
0.1% Triton X-100 in phosphate-buffered saline (PBS) for 3 min and washed three
times with PBS at room temperature. Cells were blocked with 3% bovine serum
albumin (BSA)in PBSfor1 handincubatedwithprimaryantibodies for1 hatroom
temperature. After being washed three times with PBS, slides were incubated with
fluorescein isothiocyanate (FITC)-conjugated or Alexa Fluor 546-conjugated
secondaryantibodiesfor1 hatroomtemperature.Slidesweretreatedwith1mMTO-
PRO-3 (Invitrogen) for 15 min to stain the nuclei and washed four times with PBS.
Slides were mounted with VECTASHIELD H-1000 (Vector Laboratories) and
observed under an Olympus IX70 (Olympus) inverted fluorescence microscope
coupled to a Radiance 2000 laser-scanning confocal system (Bio-Rad).
Quantitative analysis of colocalization of 14-3-3c with mitochondria, Mieap, or
lysosomes.ThecellsweresubjectedtoIFanalysisusingtheanti-14-3-3c,anti-Mieap,
and anti-LAMP1 antibodies and DsRed-mito. 14-3-3c and Mieap proteins were
detected with anti-14-3-3c antibody (green) and anti-Mieap antibody (red).
Lysosomes were detected with anti-LAMP1 antibody (red), and mitochondria were
indicated by the signals of DsRed-mito (red). The overlappings (yellow) of the 14-3-
3c (green) and mitochondrial (red), Mieap (red), or lysosomal signals (red) were
analyzedbyLuminaVisionimageanalysissoftwarein300–400cellsusingtheoptimal
thresholdparameters.Theratioofyellowtoredorgreenwaspresentedastheaverage
of the calculated values per cell with error bars.
Subcellular fractionation and proteinase K protection assay. The experiment was
performed as described previously
7. HCT116 cells were infected with Ad-LacZ, Ad-
Mieapa,andAd-MieapbatanMOIof5,and12 haftertheinfection,thecellswerec-
irradiated at 60 Gy and collected 3 days after IR. The control, Mieap-KD, and 14-3-
3c-KDcellsofA549werec-irradiatedat10Gy,andcollected3daysafterIR.Thecells
weresuspendedincoldhomogenizationbuffer(20 mMHEPES,pH7.4,and250 mM
sucrose) at 2310
7 cells/ml and homogenized using Dounce homogenization on ice.
Thehomogenizedsampleswerecentrifugedat8003gat4uCfor10 mintopelletthe
nuclear fraction. The centrifugation was repeated, and the resulting supernatant was
centrifuged at 10,000 3 ga t4 uC for 10 min to obtain a mitochondrial pellet and
cytosolic supernatant. The mitochondrial pellets were centrifuged again with fresh
homogenization buffer, and the pellets were suspended in 25 mM Tris-HCl, pH 7.4,
and 150 mM NaCl to react with the protease. The mitochondrial suspensions were
treated or not with 20 mg/ml proteinase K for 20 min on ice. Then, proteinase K was
inactivated using 2 mM PMSF for 10 min on ice. The samples were dissolved in
Laemmli buffer for SDS–PAGE, and western blotting was performed using primary
antibodies against the indicated proteins.
Establishment of Mieap KD and NIX KD cell lines using RNA interference. We
established the Mieap KD cell line using A549 cells, as described previously
7. We also
established 14-3-3c KD cell lines using A549 cells. The 14-3-3c expression was
inhibited in the cell line by retroviral expression of short-hairpin RNA (shRNAs; 14-
3-3c KD1: 59-gatccccGGAGGGTCATCAGTAGCATTGttcaagagaCAATGCTAC-
TGATGACCCTCCtttttggaaa-39, 14-3-3c KD2: 59- gatccccACGAGGACTCCT-
ACAAGGACttcaagagaGTCCTTGTAGGAGTCCTCGTtttttggaaa-39, 14-3-3c KD3:
59- gatccccGCCACTGTCGAATGAGGAAttcaagagaTTCCTCATTCG-
ACAGTGGCtttttggaaa-39)againstthe14-3-3csequence.Wealsoestablishedcontrol
celllinesbyinfectionwitharetroviralvectorcontainingshRNA(Control)againstthe
green fluorescent protein (GFP) sequence.
Analysis of oxidized proteins. For detection of carbonyl-oxidized proteins, the
control, Mieap-KD, and 14-3-3c-KD cells of A549 (3310
5 cells/6 cm-dish) were c-
irradiated at 10Gy. To evaluate the role of lysosomes in the degradation of oxidized
proteins,lysosomalenzymeinhibitors[75mlof2 mg/mlLeupeptin(Sigma)and60ml
of 5 mg/ml Pepstatin A (Sigma)] were added to the culture medium (3 ml) of the
A549controlcells2daysafterIR.Then,3daysafterIR,celllysateswereisolatedfrom
the cells. The supernatants were adjusted at 3 mg/ml protein extractions by Lowly-
protein assay Kit (Bio-Rad). To derivatize the carbonyl groups on the protein side
chains by 2,4-dinitrophenylhydrazine (DNPH), 5 ml of 12% SDS was added to 5 mlo f
protein extraction, and the mixture was incubated with 10 ml of 10 mM DNPH
solution (OxyBlot kit, Chemicon), or 10 ml of control solution without DNPH for
15 min. After neutralization, the samples were subjected to the western blot analysis
with rabbit polyclonal antibody against DNP-KLH (Invitrogen).
Fordetection of3-nitrotyrosine oxidized proteins,the control, Mieap-KD,and 14-
3-3c-KDcellsofA549(2310
4cells/wellin8wellchamber)werec-irradiatedat10Gy.
The Ad-Mieap and Ad-LacZ infected cells of HCT116 (2310
4 cells/well in 8 well
chamber) were also c-irradiated at 10Gy. To evaluate the role of lysosomes in the
degradation of oxidized proteins, lysosomal enzyme inhibitors [7.5 ml of 2 mg/ml
Leupeptin (Sigma) and 6 ml of 5 mg/ml Pepstatin A (Sigma)] or 7.5 mlo f1m M
NH4Cl was added to the culturemedium (300 ml) of the Ad-Mieap infected HCT116
cells or the A549 control cells 2 days after IR. Then, 3 days after IR, or immediately
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anti-nitrotyrosine antibody. The cells on 8-well chamber slides were fixed and
blocked, and incubated withrabbit polyclonalantibodyagainst nitrotyrosine (15100,
Upstate) in blocking solution for 1.5 h. After washing with PBS, the cells were
incubated with FITC conjugated goat anti-rabbit IgG secondary antibody (15300,
Santa cruz) for 1 h. Nucleus and mitochondria in the cells were counterstained with
TO-PRO-3 and DsRed-Mito, respectively. The nitrotyrosine signals in 300–500 cells
were analyzed by confocal microscopy. The intensity of nitrotyrosine in each cap-
tured image was analyzed by LuminaVision image analysis software (Version 2.4).
The total areas of nitrotyrosine in 300–400 cells were extracted using the optimal
thresholdparametersandcalculatedwithLuminaVisionimageanalysissoftware.The
nitrotyrosine intensity was presented as the average of the calculated values per cell
with error bars.
Quantitative analysis of MALM. MALM was evaluated as described previously
8.I n
brief,theindicatedcellsweresubjectedtoIFanalysisusinganti-LAMP1antibodyand
Ad-DsRed-mito vector. Lysosomes were detected with anti-LAMP1 antibody
(green), and mitochondria were indicated by the signals of DsRed-mito (red). The
overlapping of the mitochondrial and lysosomal signals (yellow area) were analyzed
by LuminaVision image analysis software in 300–400 cells using the optimal
threshold parameters. The yellow intensity was presented as the average of the
calculated values per cell with error bars.
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